Merck & Co. Inc. Chief Executive Kenneth Frazier will continue leading the pharmaceutical firm after he turns 65, after the company’s board decided to no longer require the CEO to retire at that age. Merck said Wednesday that Mr. Frazier will turn 65 in December of next year but plans to stay as CEO beyond that point in time. Lead board...

Source: Wall Street Journal September 26, 2018 11:15 UTC